Cargando…

Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds

Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects over 6 million people worldwide. Development of new drugs to treat this disease remains a priority since those currently available have variable efficacy and frequent adverse effects, especially during the long regimens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Peinado, Nieves, Martori, Clara, Cortes-Serra, Nuria, Sherman, Julian, Rodriguez, Ana, Gascon, Joaquim, Alberola, Jordi, Pinazo, Maria-Jesus, Rodriguez-Cortes, Alheli, Alonso-Padilla, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828178/ https://www.ncbi.nlm.nih.gov/pubmed/33445756 http://dx.doi.org/10.3390/ijms22020688

Ejemplares similares

Identification of Trypanosoma cruzi Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
por: Martinez-Peinado, Nieves, et al.
Publicado: (2020)

Immuno-metabolic profile of human macrophages after Leishmania and Trypanosoma cruzi infection
por: Ty, Maureen C., et al.
Publicado: (2019)

The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi
por: Ros-Lucas, Albert, et al.
Publicado: (2022)

Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against Trypanosoma cruzi
por: Martinez-Peinado, Nieves, et al.
Publicado: (2023)

Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi
por: Martinez-Peinado, Nieves, et al.
Publicado: (2021)

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
por: Martínez-Peinado, Nieves, et al.
Publicado: (2021)

Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantum
por: Martínez-Flórez, Alba, et al.
Publicado: (2020)

Vitamin d and leishmaniasis: Neither seasonal nor risk factor in canine host but potential adjuvant treatment through cbd103 expression
por: Martori, Clara, et al.
Publicado: (2021)

Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs
por: Barnadas-Carceller, Berta, et al.
Publicado: (2023)

High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
por: Alonso-Padilla, Julio, et al.
Publicado: (2014)

Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2022)

Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
por: Alonso-Padilla, Julio, et al.
Publicado: (2015)

Trypanosoma cruzi transmission dynamics in a synanthropic and domesticated host community
por: Flores-Ferrer, Alheli, et al.
Publicado: (2019)

Trypanosoma cruzi-infected Panstrongylus geniculatus and Rhodnius robustus adults invade households in the Tropics of Cochabamba region of Bolivia
por: Rojas-Cortez, Mirko, et al.
Publicado: (2016)

Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection
por: Hosein, Shazia, et al.
Publicado: (2015)

Construction of three new Gateway(®) expression plasmids for Trypanosoma cruzi
por: Alonso, Victoria L, et al.
Publicado: (2014)

State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
por: Gabaldón-Figueira, Juan Carlos, et al.
Publicado: (2023)

Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases
por: Martínez-Flórez, Alba, et al.
Publicado: (2020)

In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
por: Canavaci, Adriana M. C., et al.
Publicado: (2010)

In cellulo and in vivo assays for compound testing against Trypanosoma cruzi
por: Guerra-Slompo, Eloise Pavão, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells in Trypanosoma cruzi Infection
por: Fresno, Manuel, et al.
Publicado: (2021)

Geographical Distribution of Trypanosoma cruzi Genotypes in Venezuela
por: Carrasco, Hernán J., et al.
Publicado: (2012)

Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
por: Andriani, Grasiella, et al.
Publicado: (2011)

Genome Sequence of Trypanosoma cruzi Strain Bug2148
por: Callejas-Hernández, Francisco, et al.
Publicado: (2018)

Impact of Laboratory-Adapted Intracellular Trypanosoma cruzi Strains on the Activity Profiles of Compounds with Anti-T. cruzi Activity
por: Sykes, Melissa L., et al.
Publicado: (2023)

Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy
por: Leon Rodriguez, Daniel A, et al.
Publicado: (2016)

Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays
por: Abras, Alba, et al.
Publicado: (2018)

Identification of Three Classes of Heteroaromatic Compounds with Activity against Intracellular Trypanosoma cruzi by Chemical Library Screening
por: Bettiol, Esther, et al.
Publicado: (2009)

Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi
por: Mazzeti, Ana Lia, et al.
Publicado: (2019)

Antiparasitic Effect of Stilbene and Terphenyl Compounds against Trypanosoma cruzi Parasites
por: Bruno, Federica, et al.
Publicado: (2021)

Trypanosoma cruzi Antigenic Proteins Shared with Acute Lymphoblastic Leukemia and Neuroblastoma
por: Eligio García, Leticia, et al.
Publicado: (2022)

Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010)

The Complete Mitochondrial DNA of Trypanosoma cruzi: Maxicircles and Minicircles
por: Callejas-Hernández, Francisco, et al.
Publicado: (2021)

Compartmentalized Immune Response in Leishmaniasis: Changing Patterns throughout the Disease
por: Rodríguez-Cortés, Alhelí, et al.
Publicado: (2016)

Sensitivity and Specificity of two rapid tests for the diagnosis of infection by Trypanosoma cruzi in a Colombian population
por: Suescún-Carrero, Sandra Helena, et al.
Publicado: (2021)

Synthesis and Anti-Trypanosoma cruzi Activity of Diaryldiazepines
por: Menezes, Júlio César L., et al.
Publicado: (2014)

Profiling the Trypanosoma cruzi Phosphoproteome
por: Marchini, Fabricio K., et al.
Publicado: (2011)

Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014)

Endothelial Transmigration by Trypanosoma cruzi
por: Coates, Bria M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d03g6v39lal917rrt6o0k6nfvd